Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Brown (NPI 1548368509)

Field	Value
Entity Type	Individual
Organization	David Brown
Address	6560 Fannin St
City	Houston
State	TX
ZIP	77030
Taxonomy	Ophthalmology Physician
NPI Enumerated	September 20, 2006

Payer Source	Total Paid
Medicare	$5.7M
Medicaid	$0

Key Findings

This provider is an ophthalmology physician with a clear procedural and drug-focused footprint: total Medicare revenue is $5.7M and the billing mix is dominated by intravitreal biologic injections and associated retinal imaging rather than office-based E/M services. The presence of high-volume injectable drug codes such as J0178 and J2781 alongside imaging code 92134 supports a retina-focused practice model that prioritizes in-office injections and diagnostic imaging.

Revenue is highly concentrated in a very small set of drug codes: the top 3 Medicare codes by revenue (J0178, J3490, J3590) account for 75.4% of this provider's total Medicare revenue. Those three codes are reported as J0178 $2.4M (42.6%), J3490 $934.2K (16.5%), and J3590 $922.5K (16.3%), indicating that reimbursement for biologic drugs drives most of the practice’s Medicare receipts.

The code-level mix points to a high-volume intravitreal injection operation: J0178 (aflibercept) shows 3.5K claims at $694 avg paid/claim and J2781 (pegcetacoplan) shows 4.1K claims at $120 avg paid/claim, while procedure code 67028 has 2.2K claims. Combined with 3K claims for retinal imaging code 92134, this pattern is consistent with frequent, recurring injection visits supported by regular posterior-segment imaging.

Competitive standing on injection therapies is strong at the national level: J0178 ranks #114 of 3204 providers nationally (96th percentile) and J2781 ranks #8 of 490 providers nationally (99th percentile), both labeled as "notably above typical national volume" (J2781 at the very top of the distribution). High ranks for J0178 and J2781 indicate this provider is a major national-level participant for these specific intravitreal therapies, while other drug codes such as J3490 and J3590 are described as "typical, unremarkable volume" despite contributing materially to revenue.

Clinical E/M and routine ophthalmology visit codes account for a small share of Medicare revenue relative to drugs and procedures: 92014 accounts for $118.3K (2.1%) and 99204 for $12K (0.2%), whereas drug codes and injection procedure 67028 together represent a much larger portion of receipts. This split suggests the operation is monetized primarily through drug administration and imaging rather than through high volumes of higher-level office E/M billing.

This provider is effectively single-payer within the available dataset: there is no Medicaid billing on file, so Medicare ($5.7M) represents the observable public-payer footprint and any Medicaid exposure is absent from the records provided. Analysts should treat the entity as Medicare-centric when evaluating public-payer risk and market position.

The provider has long tenure in the NPI registry, enumerated on 2006-09-20 (~20 years ago), indicating an established practice presence that plausibly supports the high injection volumes and sustained Medicare revenue observed. Long enumeration combined with the high ranks on key injection codes suggests an established referral or patient-follow-up network for retinal care.

Several codes are flagged as statistical outliers or notably above typical volume in the dataset: 92134 is labeled "extreme outlier" with 3K claims and ranks #421 of 26868 providers nationally (98th percentile), J2781 is at the 99th percentile, and 67028 is labeled "notably above typical national volume" (rank #317 of 4255, 93rd percentile). At the same time, some high-dollar drug codes are described as "typical, unremarkable volume," indicating that while dollar impact is concentrated, the usage pattern for certain unclassified drug codes aligns with common national drug-billing behaviors among peers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,470	$690	$2.4M
J3490	Unclassified drugs	470	$2,010	$934.2K
J3590	Unclassified biologics	450	$2,030	$922.5K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	4,080	$120	$489.6K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,610	$220	$351.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,160	$110	$230.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,300	$90	$118.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,970	$30	$89.1K
J2778	Injection, ranibizumab, 0.1 mg	390	$170	$66.5K
92242	The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He…	60	$210	$12.1K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

David Brown — 6 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	210	610	$690	$694.9K
J2778	57	80	630	$180	$345.3K
Q5128	13	50	770	$220	$263.7K
J3590	1	40	70	$1,640	$162.7K
J2781	2	50	720	$120	$131.9K
67028	24	290	510	$90	$73K
J3490	13	350	60	$480	$54.4K
92242	11	20	50	$200	$24.4K
92235	91	160	60	$100	$21.3K
92014	74	2,700	100	$80	$21K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Brown, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
Charles Wykoff	TX	Ophthalmology Physician	$6.2M	$0
Matthew Benz	TX	Ophthalmology Physician	$5.7M	$0
Richard Lane	TX	Retina Specialist (Ophthalmology) Physician	$4.8M	$0
Tien Wong	TX	Ophthalmology Physician	$4.5M	$0
Jay Wang	FL	Medical Oncology Physician	$4.5M	$0
Joseph Sedrak	TX	MOHS-Micrographic Surgery Physician	$4.4M	$0
Ankoor Shah	TX	Ophthalmology Physician	$3.7M	$0
Jeremiah Brown	TX	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Sarah Holy	TX	Retina Specialist (Ophthalmology) Physician	$3.5M	$0

Nearby Providers

Other providers in the same ZIP code as David Brown, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Texas Children's Hospital	TX	Children's Hospital	$0	$277.4M
Texas Children's Physician Group	TX	Pediatrics Physician	$0	$160.6M
Ut Physicians	TX	Anesthesiology Physician	$0	$94.4M
Texas Children's Urgent Care	TX	Pediatrics Physician	$0	$63.7M
Memorial Hermann Health System	TX	General Acute Care Hospital	$0	$39.5M
Harris County Hospital District	TX	General Acute Care Hospital	$0	$27.7M
Baylor College Of Medicine	TX	Family Medicine Physician	$0	$18.1M
Igor Cherches	TX	Neurology Physician	$6.7M	$0
James Major	TX	Ophthalmology Physician	$3.4M	$0
Sagar Patel	TX	Ophthalmology Physician	$3.2M	$0

David Brown — Billing Profile & Reimbursement Data

Sign up for David Brown — Billing Profile & Reimbursement Data policy alerts

David Brown — Billing Profile & Reimbursement Data

Sign up for David Brown — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References